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Clostridium 
difﬁ  cile Surveillance 
Trends, Saxony, 
Germany
To the Editor: Vonberg et al. (1) 
recently commented on the increase of 
Clostridium difﬁ  cile seen in US hos-
pitals by using discharge diagnoses 
and conﬁ   rmed the observation from 
the United States (2) with hospital 
discharge data from Germany during 
2000 through 2004. C. difﬁ  cile ribo-
type 027 has recently been isolated in 
Germany (3). We further contribute 
to the assessment of C. difﬁ  cile as an 
emerging threat by looking at popula-
tion surveillance data.
C. difﬁ  cile is not a federal notiﬁ  -
able disease in Germany, which limits 
our ability to analyze national sur-
veillance trends. However, in 2002 
the state of Saxony implemented ad-
ditional mandatory surveillance of 
community- and hospital-acquired 
infectious enteritis caused by labora-
tory-conﬁ  rmed C. difﬁ  cile.
To check for an increase in noti-
ﬁ  cations due to reporting bias of gas-
troenteric diseases, we compared the 
quarterly incidence data from 2002 
through 2006 with data on Salmonella 
spp. infections (usually reported by lo-
cal general practitioners) and rotavirus 
and norovirus infections (both usually 
reported by clinics). The potential 
problem of reporting bias for gastro-
enteric diseases has been addressed re-
cently (4). Information about age and 
sex of C. difﬁ  cile patients was avail-
able for 2006 only.
Quarterly incidences for C. dif-
ﬁ  cile in Saxony were from 1.7–3.8 per 
100,000 population in 2002 and 2003 
and continued to increase to 14.8 cases 
per 100,000 population in 2006 (Fig-
ure). This constitutes a 6-fold increase 
of the yearly average of C. difﬁ  cile in-
cidence rates between 2002 and 2006. 
The third quarter of 2005 experienced a 
sharp drop that could not be explained 
retrospectively and might have resulted 
from transition to new procedures for 
data collection and management.
Gastroenteric infections showed 
clear seasonality with a slightly de-
creasing yearly trend for Salmonella 
spp. and seasonal values from 13.8 
cases per 100,000 in winter to summer 
peaks of 56.8. Rotavirus infections 
displayed an even stronger seasonal-
ity, with values from 7.0 cases per 
100,000 in summer to winter peaks 
of 140.3. Norovirus infections peaked 
again during winter, at 137.2 cases per 
100,000 but had as few as 11.0 cases 
per 100,000 during summer. Notiﬁ  ca-
tion does not suggest reporting bias of 
gastroenteric infections.
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Figure. Quarterly incidence per 100,000 population of Clostridium difﬁ  cile infections 
compared with gastroenteric infections caused by Salmonella spp., rotaviruses, and 
noroviruses in Saxony, Germany, 2002–2006. Note the log scale on the y axis.LETTERS
Elderly persons, i.e., those >65 
years of age, were affected most by C. 
difﬁ  cile infections; this age group ac-
counted for 1,506 (65%) of all cases (n 
= 2,306) in 2006. The 45- to 64-year 
age group had the next highest number 
of cases, 451 (20%). Men and women 
were affected equally in the different 
age groups; slightly more women (n = 
805) than men (n = 701) with C. dif-
ﬁ  cile infection were >65 years of age.
According to state and local 
health departments, there were no 
major health campaigns since 2004 
that might have selectively increased 
awareness for C. difﬁ  cile notiﬁ  cation. 
Our results show a continuous increase 
of cases that even reaches seasonal no-
tiﬁ  cation levels of Salmonella spp. and 
rotavirus infections, but the increase is 
difﬁ  cult to explain entirely by changes 
in reporting behavior. We emphasize 
the role of individual German states in 
setting additional surveillance targets 
for public health. Given the epidemic 
potential and the severity of the dis-
ease, especially among the elderly, 
surveillance of C. difﬁ  cile should be 
introduced throughout Germany along 
with enhanced prevention and treat-
ment strategies (5).
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ANOTHER DIMENSION
The CAT Scan
Ronald O. Valdiserri
I enter your portal through a scrim of invisible rays,
beads of energy outnumbering my regrets.
Supine on a cold bed, part supplicant, part sacriﬁ  ce.
Like all captives, fearing judgment.
Woosh, then comes the warm tingle of the dye,
everywhere at once.
It feels like a cleansing…
washing away debris, debt, equivocation.
“no,” silently, I correct myself,
acknowledging the iodine’s more melancholy assignment:
building a luminous marquee around 56 years of imperfection and wear.
And the lights blink yellow.
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